News

Singapore, October 2019 – X-ZELL has been nominated as one of 16 regional finalists of the 2019 Hello Tomorrow Singapore Challenge. Hello Tomorrow is a global non-profit organisation on a mission to accelerate deep technology research and entrepreneurship, and to...

Singapore, October 2019 – X-ZELL has been selected as one of the start-ups to be featured on A*ccelerate Technologies’ Innovation Pavilion at the upcoming SWITCH exhibition in Singapore. Short for Singapore Week of Innovation and Technology, SWITCH first came to life...

Singapore/ Essen, October 2019 – German industrial services specialist, Deutsche Industrieanlagen (DIAG), has officially joined X-ZELL’s US$3m Seed+ funding round. Ranked amongst Asia’s 50 most innovative health technology start-ups for two years running, X-ZELL...

Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running. Every year, the prestigious list is compiled by Singapore-based analytics and advisory firm, Galen Growth Asia, which has developed a...

Bangkok/Basel, August 2019 (via PR Newswire) – An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to detect clinically significant prostate cancer in high-risk patients, as...

Singapore, July 2019 – Singapore-based rare cell detection specialist, X-ZELL, is about to embark on the most ambitious research and innovation project in the company’s history. Nicknamed Cloud Atlas, the landmark project will consolidate the image material collected...

Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between Changi Airport and the city's vibrant Central Business...

Singapore, April 2019 – Rare cell detection specialist, X-ZELL, has been shortlisted as a Finalist for the 2019 HealthInvestor Asia Awards. According to HealthInvestor Asia, X-ZELL has been nominated in the “Diagnostics Deal of the Year” category following the signing...

Singapore, February 2019 – Rare cell detection specialist X-ZELL is proud to announce the world premiere of the world’s first 8-channel multiplexing technology, Cryoimmunostaining™ . Originally designed to enable the company’s headline-making research into...

Singapore, February 2019 – Singaporean medical technology start-up X-ZELL will preview the production version of the world's first slide-based, eight-channel immunostaining solution at the 2019 Medlab Asia Pacific trade show, to be held at Singapore’s Suntec...